Two decades of experience with cyclosporine in renal transplantation in Helsinki

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S94-S98

  Salmela, K T ^a   Kyllonen L E J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER DONOR; CALCULATION; CREATININE CLEARANCE; FEMALE; FINLAND; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME;

EID: 19244383638     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.01.036     Document Type: Article

References (10)

1. Halloran P.F., Aprile M.A., Farewell V., et al. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation. 46:1988;223.
2. Humar A., Ramcharan T., Kandaswamy R., et al. Risk factors for slow graft function after kidney transplants a multivariate analysis. Clin Transplant. 16:2002;425.
3. Kyllönen L., Salmela K., Eklund B., et al. Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int. 13:2000;122.
4. Kyllönen L.E., Salmela K.T., Koskimies S.A. The prognostic value of conversion of complement dependent cytotoxic t-cell crossmatch test after renal transplantation. Transpl Int. 12:1999;423.
5. Cho Y.W., Terasaki P.I. Long-term survival. Cecka J.M., Terasaki P.I. Clinical Transplants, 1988. 1988;277 Calif: UCLA Tissue Typing Laboratory, Los Angeles.
6. Shoskes D.A., Cecka J.M. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation. 66:1998;1697.
7. Cecka J.M. The UNOS scientific renal transplant registry. Clinical Transplants 1998. 1998;UCLA Tissue Typing Laboratory, Los Angeles, Calif.
8. Meier-Kriesche H.-U., Steffen B.J., Hochberg A.M., et al. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation. 75:2003;1341.
9. Hariharan S., McBride M.A., Cherikh W.S., et al. Posttransplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 62:2002;311.
10. Opelz G., Döhler B. Cyclosporine and long-term kidney graft survival. Transplantation. 72:2001;1267.